Skip NavigationSkip to Content
Return Return to Search Results

Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma

  1. Author:
    Chaisaingmongkol, Jittiporn
    Budhu, Anuradha
    Dang, Hien
    Rabibhadana, Siritida
    Pupacdi, Benjarath
    Kwon, So Mee
    Forgues, Marshonna
    Pomyen, Yotsawat
    Bhudhisawasdi, Vajarabhongsa
    Lertprasertsuke, Nirush
    Chotirosniramit, Anon
    Pairojkul, Chawalit
    Auewarakul, Chirayu U
    Sricharunrat, Thaniya
    Phornphutkul, Kannika
    Sangrajrang, Suleeporn
    Cam, Maggie
    He, Ping
    Hewitt, Stephen M
    Ylaya, Kris
    Wu, Xiaolin
    Andersen, Jesper B
    Thorgeirsson, Snorri S
    Waterfall, Joshua J
    Zhu, Yuelin J
    Walling, Jennifer
    Stevenson, Holly S
    Edelman, Daniel
    Meltzer, Paul S
    Loffredo, Christopher A
    Hama, Natsuko
    Shibata, Tatsuhiro
    Wiltrout, Robert H
    Harris, Curtis C
    Mahidol, Chulabhorn
    Ruchirawat, Mathuros
    Wang, Xin W

  2. Author Address

    Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok 10210, Thailand; Center of Excellence on Environmental Health and Toxicology, Office of Higher Education Commission, Ministry of Education, Bangkok 10400, Thailand., Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok 10210, Thailand., Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok 10210, Thailand., Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand., Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand., HRH Princess Chulabhorn College of Medical Science, Bangkok 10210, Thailand., Chulabhorn Hospital, Bangkok 10210, Thailand., Rajavej Hospital, Chiang Mai 50000, Thailand., National Cancer Institute, Bangkok 10400, Thailand., FDA, Silver Spring, MD 20993, USA., Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Biotech Research and Innovation Centre (BRIC), Department of Health and Medical Sciences, University of Copenhagen, Copenhagen 2200, Denmark., Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Georgetown University Medical Center, Washington, DC 20057, USA., Division of Cancer Genomics, National Cancer Center Research Institute, The University of Tokyo, Tokyo 104-0045, Japan., Division of Cancer Genomics, National Cancer Center Research Institute, The University of Tokyo, Tokyo 104-0045, Japan; Laboratory of Molecular Medicine, Human Genome Center, The Institute of Medical Science, The University of Tokyo, Tokyo 104-0045, Japan., Cancer Inflammation Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA., Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok 10210, Thailand; HRH Princess Chulabhorn College of Medical Science, Bangkok 10210, Thailand. Electronic address: pc@cri.or.th., Laboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok 10210, Thailand; Center of Excellence on Environmental Health and Toxicology, Office of Higher Education Commission, Ministry of Education, Bangkok 10400, Thailand. Electronic address: mathuros@cri.or.th., Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: xw3u@nih.gov.,
    1. Year: 2017
    2. Date: Jul 10
    3. Epub Date: 2017 Jun 22
  2. Journal: Cancer Cell
    1. 32
    2. 1
    3. Pages: 57-70
  4. Type of Article: Article
  5. ISSN: 1535-6108
  1. Abstract:

    Intrahepatic cholangiocarcinoma (ICC) and hepatocellular carcinoma (HCC) are clinically disparate primary liver cancers with etiological and biological heterogeneity. We identified common molecular subtypes linked to similar prognosis among 199 Thai ICC and HCC patients through systems integration of genomics, transcriptomics, and metabolomics. While ICC and HCC share recurrently mutated genes, including TP53, ARID1A, and ARID2, mitotic checkpoint anomalies distinguish the C1 subtype with key drivers PLK1 and ECT2, whereas the C2 subtype is linked to obesity, T cell infiltration, and bile acid metabolism. These molecular subtypes are found in 582 Asian, but less so in 265 Caucasian patients. Thus, Asian ICC and HCC, while clinically treated as separate entities, share common molecular subtypes with similar actionable drivers to improve precision therapy. Published by Elsevier Inc.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1016/j.ccell.2017.05.009
  3. PMID: 28648284
  4. View record in Web of Science®
  5. WOS: 000405112300007

Library Notes

  1. Fiscal Year: FY2016-2017
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel